|Table of Contents|

Incidence,mortality and survival rate of lung cancer in Chongqing,2016

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 11
Page:
2116-2120
Research Field:
Publishing date:

Info

Title:
Incidence,mortality and survival rate of lung cancer in Chongqing,2016
Author(s):
DING Xianbin1; LYU Xiaoyan1; JIAO Yan1; GAO Yang1; XIONG Juan2; CHEN Ting1; XU Jie1; DING Rui3
1.Institute of Non-communicable Disease Control and Prevention,Chongqing Center for Disease Control and Prevention,Chongqing 400042,China;2.The Second People's Hospital of Yubei District,Chongqing 401147,China;3First Clinical College of Chongqing Medical University,Chongqing 400016,China.
Keywords:
lung cancer; incidence; mortality; survival rate
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2023.11.026
Abstract:
Objective:To analyze the incidence,mortality and survival rate of lung cancer in Chongqing,2016 and provide the suggestion for lung cancer prevention and control.Methods:Lung cancer cases reported from districts and counties in Chongqing entered into this study in 2016.All lung cancer cases were followed up for five years by active and passive follow up to survey the living status.All follow-up information was reported to Chongqing cancer registry and follow-up information system.Indicators such as the incidence,age standardization incidence rate by Chinese standardization population(ASIRC),mortality,age standardization mortality rate by Chinese standardization population(ASMRC),survival rate were calculated by SPSS 25.0.ASIRC and ASMRC was standardized by national standard population proportion in 2000.The difference of the incidence and mortality between male and female,urban and rural area was compared by Chi-square test.The observed survival rate was calculated by survival life table.The average survival life time was calculated by Kaplan-Meier.The difference of survival rate of lung cancer between male and female,urban and rural area was compared by Log Rank of Mantel-Cox.Results:The incidence and ASIRC of lung cancer were 79.13/100 000 and 44.82/100 000 respectively in Chongqing,2016.The incidence of lung cancer among male residents(110.33/100 000) was higher than that among female residents(46.77/100 000)(χ2=63.018，P<0.001).The incidence of lung cancer in urban area(87.65/100 000) was higher than that in rural area(75.86/100 000)(χ2=10.47,P=0.001).The mortality and ASMRC of lung cancer were 65.96/100 000 and 33.77/100 000 respectively in Chongqing,2016.The mortality of lung cancer among male residents(95.40/100 000) was higher than that among female residents(35.95/100 000)(χ2=64.43，P<0.001).The mortality of lung cancer in urban area(73.30/100 000) was higher than that in rural area(60.83/100 000)(χ2=12.28，P<0.001).A total of 18 842 cases of lung cancer were followed up for five years.The average survival year of lung cancer was 2.11(2.07,2.14) years after five years of follow up.The survival rate of 1 year,2 years,3 years,4 years and 5 years were 41.84%，33.41%，29.97%，28.04% and 26.54% respectively.The survival rate of lung cancer among female residents was higher than that among male residents(P<0.05).The survival rate of lung cancer in urban area was higher than that in rural area(P<0.05).Conclusion:The incidence and mortality of lung cancer was high in Chongqing.However,the survival rate of lung cancer was low.It should be conducted the prevention,early screening,standard diagnosis and treatment targeting male and rural residents in Chongqing.

References:

[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］.A Cancer Journal for Clinicians,2021,71(3):209-249.
[2］郝捷,魏文强.2019中国肿瘤登记年报［M］.北京：人民卫生出版社，2021:145-150. HAO J,WEI WQ.Cancer registry annual report,2019［M］.Beijing:People Medical Publishing House,2021:145-150.
[3］丁贤彬,唐文革,曾永胜,等.2010-2017年重庆市肺癌发病和死亡趋势变化［J］.中国肿瘤,2019,28(08):577-582. DING XB,TANG WG,ZENG YS,et al.Trend analysis of lung cancer incidence and mortality between 2010 and 2017 in Chongqing［J］.China Cancer,2019,28(08):577-582
[4］丁贤彬,吕晓燕,毛德强,等.2006-2020年重庆市肺癌发病率长期变化趋势［J］.中国慢性病预防与控制,2022,30(4):273-277. DING XB,LYU XY,MAO DQ,et al.Long-term trend of lung cancer incidence between 2006 and 2020 in Chongqing［J］.Chinese Journal of Prevention and Control of Chronic Diseases,2022,30(4):273-277.
[5］健康中国行动推进委员会.健康中国行动(2019-2030年):总体要求、重大行动及主要指标［J］.中国循环杂志,2019,34(9):846-858. Promotion Committee of Healthy China Action.Healthy China Action(2019-2030)：General requirements,major actions and major indicators ［J］.Chinese Journal of Circulation,2019,34(9):846-858.
[6]CAO M,CHEN W.Epidemiology of lung cancer in China［J］.Thoracic Cancer,2019,10(1):3-7.
[7］王媛媛,毕玉,王在翔,等.山东省肺癌患者生存分析［J］.中国卫生统计,2018,35(1):111-113,116. WANG YY,BI Y,WANG ZX,et al.Survival analysis of lung cancer in Shandong Province［J］.Chinese Journal of Health Statistics,2018,35(1):111-113,116.
[8］罗胜兰.浙江省常见恶性肿瘤生存分析［D］.宁波:宁波大学,2014. LUO SL.Survival analysis of common cancers in Zhejiang Province,China［D］.Ningbo:Ningbo University,2014.
[9］何美,李必波,杜佳,等.2001-2018年重庆市肺癌患者临床特征及生存分析［J］.中国肿瘤,2020,29(11):865-870. HE M,LI BB,DU J,et al.Clinical characteristics and survival of lung cancer patients in Chongqing，2001-2018［J］.China Cancer,2020,29(11):865-870.
[10］成姝雯,赵叶茂,胥馨尹,等.2016年四川省肿瘤登记地区肺癌发病和死亡情况分析［J］.肿瘤预防与治疗,2022,35(2):142-146. CHENG SW,ZHAO YM,XU XY,et al.Registered lung cancer incidence and mortality in Sichuan Province,2016［J］.Journal of Cancer Control Treatment,2022,35(2):142-146.
[11］王艳平,邱琳,武萌,等.2016年陕西省恶性肿瘤发病与死亡分析［J］.实用肿瘤学杂志,2022,36(1):1-6. WANG YP,QIU L,WU M,et al.Analysis of the incidence and mortality of malignant tumors in Shaanxi Province,2016［J］.Practical Oncology Journal,2022,36(1):1-6.
[12］韩仁强,武鸣,缪伟刚,等.2016年江苏省恶性肿瘤流行情况分析［J］.实用肿瘤学杂志,2020,34(4):291-297. HAN RQ,WU M,MIAO WG,et al.Malignant tumor epidemiology in Jiangsu Province,2016［J］.Practical Oncology Journal,2020,34(4):291-297.
[13］李秋林,曹骥,容敏华,等.2016年广西肿瘤登记地区恶性肿瘤发病和死亡分析［J］.中国癌症防治杂志,2020,12(1):44-51. LI QL,CAO J,RONG MH,et al.Analysis of cancer incidence and mortality in Guangxi cancer registration areas,2016［J］.Chinese Journal of Oncology Prevention and Treatment,2020,12(1):44-51.
[14］许可葵,王静,廖先珍,等.2016年湖南省肿瘤登记地区恶性肿瘤发病和死亡分析［J］.中国肿瘤,2021,30(04):250-261. XU KK,WANG J,LIAO XZ,et al.Incidence and mortality of cancer in Hunan cancer registries,2016［J］.China Cancer,2021,30(04):250-261.
[15］文洪梅,陈杨,石青萍,等.2016年云南省肿瘤登记地区恶性肿瘤的发病和死亡分析［J］.实用肿瘤学杂志,2020,34(06):485-490. WEN HM,CHEN Y,SHI QP,et al.Analysis of cancer incidence and mortality in Yunnan cancer registry,2016［J］.Practical Oncology Journal,2020,34(06):485-490.
[16］孙高敏,许武成,周杜辉,等.重庆市近11年空气污染指数变化的小波变换分析［J］.后勤工程学院学报,2012,28(02):70-75. SUN GM,XU WC,ZHOU DH,et al.Wavelet transformation analysis of Chongqing air pollution index change in recent 11 years［J］.Journal of Logistical Engineering University,2012,28(02):70-75.
[17］王艳平,武萌,刘蓉,等.2013-2017年陕西省肿瘤登记地区肺癌发病与死亡趋势分析［J］.中国肿瘤,2022,31(8):1-7. WANG YP,WU M,LIU R,et al.Trends of incidence and mortality of lung cancer in Shaanxi cancer registration areas from 2013 to 2017［J］.China Cancer,2022,31(8):1-7.
[18］翟玉庭,郝建辉,宁巍巍,等.2008-2017年山东省招远市肺癌发病和死亡及生存率分析［J］.中华肿瘤防治杂志,2021,28(15):1125-1130. ZHAI YT,HAO JH,NING WW,et al.Incidence,mortality and survival rate of lung cancer in Zhaoyuan,Shandong,2008-2017［J］.Chinese Journal of Cancer Prevention and Treatment,2021,28(15):1125-1130.
[19］于丽娅,穆慧娟,礼彦侠,等.辽宁省城市社区2000年肺癌患者分期和治疗方式与5年生存率关联分析［J］.中华肿瘤防治杂志,2018,25(21):1477-1482. YU LY,MU HJ,LI YX,et al.Correlation of 5-year survival of lung cancer patients with stage and treatment method in urban communities of Lioaning Province,2000［J］.Chinese Journal of Cancer Prevention and Treatment,2018,25(21):1477-1482.
[20]BRAINSON CF,HUANG B,CHEN Q,et al.Description of a lung cancer hotspot:Disparities in lung cancer histology,incidence and survival in kentucky and appalachian kentucky［J］.Clinical Lung Cancer,2021,22(6):e911-e920.
[21]MUSIKA W,KAMSA-ARD S,JIRAPORNKUL C,et al.Lung cancer survival with current therapies and new targeted treatments:A comprehensive update from the srinagarind hospital-based cancer registry from(2013 to 2017)［J］.Asian Pacific Journal of Cancer Prevention,2021,22(8):2501-2507.
[22］SMITH CB,BONOMI M,PACKER S,et al.Disparities in lung cancer stage,treatment and survival among American Indians and Alaskan Natives［J］.Lung Cancer,2011,72(2):160-164.
[23］苏雷,魏秀芹.从我国肺癌防控发展看早期肺癌的诊疗策略［J］.医学研究杂志,2020,49(09):1-5. SHU L,WEI XQ.Strategy of diagnosis and treatment from the development of lung cancer prevention and control in China［J］.Journal of Medical Research,2020,49(09):1-5.
[24］杜佳,何美,邱惠,等.2012-2017年重庆城市居民肺癌筛查结果分析［J］.中国肿瘤,2018,27(05):328-332. DU J,HE M,QIU H,et al.Results of lung cancer screening among urban residents in Chongqing,2012-2017［J］.China Cancer,2018,27(05):328-332.
[25］赫捷,李霓,陈万青,等.中国肺癌筛查与早诊早治指南(2021,北京)［J］.中华肿瘤杂志,2021,43(03):243-268. HE J,LI N,CHEN WQ,et al.China guideline for the screening and early detection of lung cancer(2021,Beijing)［J］.Chinese Journal of Oncology,2021,43(03):243-268.
[26］INAGE T,NAKAJIMA T,YOSHINO I,et al.Early lung cancer detection［J］.Clinical Chest Medicine,2018,39(1):45-55.
[27]SACHS E,SARIPY U,JACKSON V.Sex and survival after surgery for lung cancer:A Swedish nationwide cohort［J］.Chest,2021,159(5):2029-2039.
[28]KINOSHITA FL,ITO Y,MORISHIMA T,et al.Sex differences in lung cancer survival:long-term trends using population-based cancer registry data in Osaka,Japan［J］.Japanese Journal of Clinical Oncology,2017,47(9):863-869.
[29]JEON J,HOLFORD TR,LEVY DT,et al.Smoking and lung cancer mortality in the United States from 2015 to 2065:A comparative modeling approach［J］.Annals of Internal Medicine,2018,169(10):684-693.
[30]FINKE I,BEHRENS G,WEISSER L,et al.Socioeconomic differences and lung cancer survival-systematic review and Meta-analysis［J］.Frontiers in Oncology,2018,27(8):536.
[31]FINKE I,BEHRENS G,SCHWETTMANN L,et al.Socioeconomic differences and lung cancer survival in Germany:Investigation based on population-based clinical cancer registration ［J］.Lung Cancer,2020,142:1-8.
[32]FORREST LF,ADAMS J,WAREHAM H,et al.Socioeconomic inequalities in lung cancer treatment:systematic review and meta-analysis［J］.PLoS Medicine,2013,10(2):e1001376.

Memo

Memo:
重庆市科卫联合项目（编号：2021MSXM198）
Last Update: 2023-04-28